Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-12-19
1991-12-03
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514291, 540524, 546 89, 546 15, 544238, 544361, C07D491052, A61K 3144, A61K 3147
Patent
active
050700880
ABSTRACT:
Novel calcium channel blockers having the formula ##STR1## wherein X is oxygen or sulfur and wherein R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 are as defined herein, are disclosed. These compounds are useful, for example, as anti-ischemic agents.
REFERENCES:
patent: 4086349 (1978-04-01), Morinaka et al.
V. A. Ashwood et al., "Synthesis and Antihypertensive Activity of 4-(Cyclic Amido)--2H--1-Benzopyrans", J. Med. Chem., 1986, 29, pp. 2194-2201.
Babajko Suzanne E.
E. R. Squibb & Sons Inc.
Furman Jr. Theodore R.
Rotman Alan L.
LandOfFree
Pyranyl quinoline calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyranyl quinoline calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyranyl quinoline calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1697141